Viewing StudyNCT05775900



Ignite Creation Date: 2024-05-06 @ 6:45 PM
Last Modification Date: 2024-10-26 @ 2:54 PM
Study NCT ID: NCT05775900
Status: RECRUITING
Last Update Posted: 2024-03-21
First Post: 2023-02-25

Brief Title: Efficacy and Safety of Triweekly Cetuximab in Combination With Capecitabine as First-line Maintenance Treatment for KRASBRAF Wild-type Metastatic Colorectal Cancer
Sponsor: Sun Yat-sen University
Organization: Sun Yat-sen University

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-02-01
Start Date Type: ACTUAL
Primary Completion Date: 2024-12-31
Primary Completion Date Type: ESTIMATED
Completion Date: 2024-12-31
Completion Date Type: ESTIMATED
First Submit Date: 2023-02-25
First Submit QC Date: March 7 2023
Study First Post Date: 2023-03-20
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-03-19
Last Update Post Date: 2024-03-21
Last Update Post Date Type: ACTUAL